Page 74 - Drug Class Review
P. 74
Page 67 of 205
Drug Effectiveness Review Project
Alzheimer Drugs Authors: Birks et al. 32 Year: 2004 Country: Multinational Review funded by NHS R&D UK Study design: Meta-analysis Number of patients: 17 trials contributed 4,365 participants; studies ranged from 12 - 566 participants To assess whether DON improves the well-being of patients with dementia due to AD A total of 17 placebo-controlled RCT studies were included, 13 of which provide sufficient details for analysis Trials completed before October 9, 2002 that were included in the Specialized Register of the Cochrane Dementia and Cognitive Improvement Group Unconfo
Final Report Update 1 Efficacy/Effectiveness STUDY: FUNDING: DESIGN: AIMS OF REVIEW: STUDIES INCLUDED IN META-ANALYSIS TIME PERIOD COVERED: CHARACTERISTICS OF INCLUDED STUDIES: CHARACTERISTICS OF INCLUDED POPULATIONS: Alzheimer's Drugs
